NT PHARMA (1011.HK)
Market: HKEX |
Currency: HKD
Address: Cosco Tower
China NT Pharma Group Company Limited, together with its subsidiaries, engages in the investment, research and development, manufacturing, sales, and distribution of pharmaceutical products in the People's Republic of China. It manufactures, sells, and trades in prescription medicines; offers products in the tumor and blood system diseases, digestive system diseases, central nervous system diseases, diseases of respiratory system, and other therapeutic fields; and produces and sells NT branded products. The company also provides marketing and promotion services to suppliers, and logistics and consulting services. China NT Pharma Group Company Limited was founded in 1995 and is headquartered in Central, Hong Kong.
Show more
📈 NT PHARMA Historical Chart
📊 Statistics
-
Analyst 1 Year Price Target:
-
-
Upside/Downside from Analyst Target:
-
-
Broker Call:
-
-
Dividend Minimum 3 Year Yield:
0.00%
-
EPS Growth Range (1Y):
25-50%
-
Net Income Growth Range (1Y):
10-25%
-
Revenue Growth Range (1Y):
<0%
💰 Dividend History
| Year |
Annual Yield (%) |
Total Amount |
Current Yield (%) |
Ex Date |
Pay Date |
Particulars |
| 2024 |
- |
$0.100000 |
- |
2024-07-03 |
- |
Stock split |
|
Total Amount for 2024: $0.100000 |
| 2018 |
- |
$0.350000 |
- |
2018-07-10 |
- |
Dividend payout |
|
Total Amount for 2018: $0.350000 |
| 2017 |
- |
$0.250000 |
- |
2017-06-08 |
- |
Dividend payout |
|
Total Amount for 2017: $0.250000 |
| 2016 |
- |
$0.100000 |
- |
2016-05-31 |
- |
Dividend payout |
|
Total Amount for 2016: $0.100000 |
📅 Earnings & EPS History for NT PHARMA
| Date | Reported EPS |
|---|
| 2025-03-31 | - |
📰 Related News & Research
No related articles found for "nt pharma".
